Barrowcliffe T W, Havercroft S J, Kemball-Cook G, Lindahl U
Biochem J. 1987 Apr 1;243(1):31-7. doi: 10.1042/bj2430031.
The influence of Ca2+, phospholipid and Factor V was determined on the rate of inactivation of Factor Xa by antithrombin III, in the absence and in the presence of unfractionated heparin and of three high-affinity heparin oligosaccharides in the Mr range 1500-6000. In the absence of heparin the addition of Ca2+, phospholipid and Factor V caused a 4-fold decrease in rate of inactivation of Factor Xa. As concentrations of unfractionated heparin were increased the protective effect of Ca2+/phospholipid/Factor V was gradually abolished, and at a concentration of 2.4 nM there were no differences in rates of neutralization of Factor Xa in the presence or absence of Ca2+, phospholipid and Factor V. In contrast, heparin decasaccharide (Mr 3000) and pentasaccharide (Mr 1500) fragments were unable to overcome the protective effect of Ca2+/phospholipid/Factor V; in the presence of these components their catalytic efficiencies were 16-fold and 40-fold less respectively than that of unfractionated heparin. A heparin 20-22-saccharide fragment (Mr approx. 6000) gave similar inactivation rates in the presence and in the absence of Ca2+/phospholipid/Factor V. Human and bovine Factor Xa gave similar results. These results indicate that in the presence of Ca2+/phospholipid/Factor V optimum inhibition of Factor Xa requires a saccharide sequence of heparin additional to that involved in binding to antithrombin III. The use of free enzyme for the assessment of anti-(Factor Xa) activity of low-Mr heparin fractions could give misleading results.
在不存在和存在未分级肝素以及三种分子量范围在1500 - 6000的高亲和力肝素寡糖的情况下,测定了Ca2 +、磷脂和因子V对抗凝血酶III灭活因子Xa速率的影响。在不存在肝素的情况下,添加Ca2 +、磷脂和因子V会使因子Xa的灭活速率降低4倍。随着未分级肝素浓度的增加,Ca2 + /磷脂/因子V的保护作用逐渐消失,在浓度为2.4 nM时,无论是否存在Ca2 +、磷脂和因子V,因子Xa的中和速率均无差异。相比之下,肝素十糖(分子量3000)和五糖(分子量1500)片段无法克服Ca2 + /磷脂/因子V的保护作用;在这些成分存在的情况下,它们的催化效率分别比未分级肝素低16倍和40倍。一种20 - 22糖的肝素片段(分子量约6000)在存在和不存在Ca2 + /磷脂/因子V的情况下具有相似的灭活速率。人源和牛源因子Xa得到了相似的结果。这些结果表明,在存在Ca2 + /磷脂/因子V的情况下,对因子Xa的最佳抑制需要肝素的糖序列,该序列除了与抗凝血酶III结合所涉及的序列外。使用游离酶评估低分子量肝素组分的抗(因子Xa)活性可能会得出误导性结果。